ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ANI Pharmaceuticals (ANIP) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, January 14, 2025, at 2:15pm PST/5:15pm EST in San Francisco. Key executives presenting include President and CEO Nikhil Lalwani, CFO Stephen Carey, and CMO Dr. Mary Pao.
The presentation will be available via live webcast and can be accessed through the company's website at www.anipharmaceuticals.com under the Investors section's Events and Presentations area. An archived version of the webcast will remain accessible for 90 days following the event.
ANI Pharmaceuticals (ANIP) ha annunciato la sua partecipazione al 43° Annuale J.P. Morgan Healthcare Conference. La presentazione si svolgerà martedì 14 gennaio 2025, alle 14:15 PST/17:15 EST a San Francisco. I principali dirigenti che presenteranno includono il Presidente e CEO Nikhil Lalwani, il CFO Stephen Carey e il CMO Dr. Mary Pao.
La presentazione sarà disponibile tramite webcast in diretta e potrà essere accessibile tramite il sito web dell'azienda all'indirizzo www.anipharmaceuticals.com nella sezione Investitori, sotto la voce Eventi e Presentazioni. Una versione archiviata del webcast rimarrà accessibile per 90 giorni dopo l'evento.
ANI Pharmaceuticals (ANIP) ha anunciado su participación en la 43ª Conferencia Anual J.P. Morgan Healthcare. La presentación se llevará a cabo el martes 14 de enero de 2025, a las 2:15 p. m. PST/5:15 p. m. EST en San Francisco. Los ejecutivos clave que presentarán incluyen al Presidente y CEO Nikhil Lalwani, al CFO Stephen Carey y a la CMO Dr. Mary Pao.
La presentación estará disponible a través de una transmisión en vivo y se podrá acceder a ella a través del sitio web de la empresa en www.anipharmaceuticals.com en la sección de Inversores, bajo la área de Eventos y Presentaciones. Una versión archivada de la transmisión estará accesible durante 90 días después del evento.
ANI Pharmaceuticals (ANIP)는 제43회 연례 J.P. Morgan Healthcare Conference에 참여한다고 발표했습니다. 발표는 2025년 1월 14일 화요일 오후 2시 15분 PST/오후 5시 15분 EST에 샌프란시스코에서 열립니다. 발표할 주요 임원으로는 사장 겸 CEO Nikhil Lalwani, CFO Stephen Carey, CMO Dr. Mary Pao가 포함됩니다.
발표는 라이브 웹캐스트를 통해 제공되며, 회사 웹사이트 www.anipharmaceuticals.com의 투자자 섹션의 이벤트 및 발표 영역에서 액세스할 수 있습니다. 웹캐스트의 아카이브 버전은 이벤트 후 90일 동안 접근 가능합니다.
ANI Pharmaceuticals (ANIP) a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. La présentation aura lieu le mardi 14 janvier 2025, à 14h15 PST/17h15 EST à San Francisco. Les principaux dirigeants qui présenteront comprennent le Président et CEO Nikhil Lalwani, le CFO Stephen Carey et le CMO Dr. Mary Pao.
La présentation sera disponible via un webcast en direct et pourra être consultée sur le site web de la société à l'adresse www.anipharmaceuticals.com dans la section Investisseurs sous la rubrique Événements et Présentations. Une version archivée du webcast restera accessible pendant 90 jours après l'événement.
ANI Pharmaceuticals (ANIP) hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare Conference bekannt gegeben. Die Präsentation findet am Dienstag, den 14. Januar 2025, um 14:15 Uhr PST/17:15 Uhr EST in San Francisco statt. Zu den wichtigsten Führungskräften, die präsentieren, gehören Präsident und CEO Nikhil Lalwani, CFO Stephen Carey und CMO Dr. Mary Pao.
Die Präsentation wird über einen Live-Webcast verfügbar sein und kann über die Unternehmenswebsite unter www.anipharmaceuticals.com im Bereich Investoren unter Veranstaltungen und Präsentationen abgerufen werden. Eine archivierte Version des Webcasts bleibt 90 Tage nach der Veranstaltung zugänglich.
- None.
- None.
PRINCETON, N.J., Dec. 30, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer; Stephen Carey, Chief Financial Officer; and Dr. Mary Pao, Chief Medical Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 2:15pm PST/5:15pm EST, in San Francisco.
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) presenting at the J.P. Morgan Healthcare Conference 2025?
How can investors watch ANI Pharmaceuticals' J.P. Morgan Healthcare Conference presentation?
How long will the replay of ANIP's J.P. Morgan Healthcare Conference presentation be available?
Which executives from ANI Pharmaceuticals will present at the 2025 J.P. Morgan Healthcare Conference?
